Abigail Hanby

Abigail gained a broad understanding of all aspects of chemistry during her Master’s degree at the University of Oxford, in which she achieved First Class honours. While studying at Oxford, she received a number of academic awards, including a Jesus college scholarship and the Woodward, Downs, and Stachulski prizes for her performance in examinations. She also gained industrial experience at GlaxoSmithKline and completed a research project in organic chemistry.

In 2017 she began her PhD at the University of Cambridge as a Vice-Chancellor’s Award scholar. Her PhD research focused on the development of next-generation antibody-based therapeutics as well as a novel fragment screening collection. Not only did this provide Abigail with an excellent understanding of organic synthesis and protein modification, but it also involved experience with various spectroscopic and analytical techniques such as NMR, LC-MS, and SDS-PAGE. Her research has yielded several high-quality publications.

Throughout her studies, Abigail also enjoyed learning about the commercialisation of technology. This led her to completing an extracurricular entrepreneurship programme at the Judge Business School, University of Cambridge, in which she received a distinction.